Curt D. Haffner

Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR

Patrick Maloney, Derek J. Parks, Curt D. Haffner et al. · Journal of Medicinal Chemistry · 2000 · 524 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

Marcos L. Sznaidman, Curt D. Haffner, Patrick Maloney et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 311 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

Curt D. Haffner, J. David Becherer, Eric E. Boros et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP)

Curt D. Haffner, Caroline J. Diaz, Aaron B. Miller et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 62 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +7

6-Azasteroids: Structure-Activity Relationships for Inhibition of Type 1 and 2 Human 5.alpha.-Reductase and Human Adrenal 3.beta.-Hydroxy-.DELTA.5-steroid Dehydrogenase/3-Keto-.DELTA.5-steroid Isomerase

Stephen V. Frye, Curt D. Haffner, Patrick Maloney et al. · Journal of Medicinal Chemistry · 1994 · 59 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17